TSC2 variations were identified in 8.5% of patients and were predominantly linked to earlier epilepsy onset and a higher prevalence of DD/ID, consistent with prior studies reporting TSC2 variations in 6%–10% of pediatric epilepsy cohorts (Crino, 2011). This evidence concerns the gene TSC2 and epilepsy.